biostudies-literatureKundi HTürkiye Bilimsel ve Teknolojik Araştirma Kurumu100183https://www.ebi.ac.uk/biostudies/studies/S-EPMC8589716biostudies-literatureUnknown10<h4>Background</h4>Several countries have increasingly focused on improving care for acute myocardial infarction (AMI), heart failure (HF), and pneumonia to reduce their readmissions and mortality rates. Frailty is becoming increasingly important to accurately predict healthcare utilization for the aging population. The preferred method for the measurement of frailty remains unclear, and current risk-adjustment models do not account for frailty. We sought to compare commonly used frailty indices in terms of the ability to predict clinical adverse outcomes in AMI, HF, and pneumonia patients.<h4>Methods</h4>A nationwide cohort study included AMI, HF, and pneumonia with 65 years and older patients in the Turkey between January 1 and December 31, 2018. The primary predictor of interest was fraThe Lancet regional health. EuropeAssociation of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey.PMC8589716120S422Coskun NKundi HYesiltepe MfalseAssociation of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey.<h4>Background</h4>Several countries have increasingly focused on improving care for acute myocardial infarction (AMI), heart failure (HF), and pneumonia to reduce their readmissions and mortality rates. Frailty is becoming increasingly important to accurately predict healthcare utilization for the aging population. The preferred method for the measurement of frailty remains unclear, and current risk-adjustment models do not account for frailty. We sought to compare commonly used frailty indices in terms of the ability to predict clinical adverse outcomes in AMI, HF, and pneumonia patients.<h4>Methods</h4>A nationwide cohort study included AMI, HF, and pneumonia with 65 years and older patients in the Turkey between January 1 and December 31, 2018. The primary predictor of interest was fra2021-01-01T00:00:00Z2021 Nov2025-04-18T12:09:17.783Z2022-02-11T13:14:03.638ZS-EPMC85897163480606310.1016/j.lanepe.2021.100183